ABSTRACT
Purpose To observe the changes of histopathology and expression levels of ER, PR, HER-2 and Ki-67 in breast cancer after neoadjuvant chemotherapy (NTC), and to evaluate the relationship between the curative effect and clinico-pathological characteristics of breast cancer. Methods 93 ca-ses of invasive breast cancer with NTC were collected and retro-spectively analyzed. Pathologic evaluation of chemotherapeutic effect were evaluated by Miller-Payne (MP) grading system. Results Tumor cells, tumor stroma and lymph nodes status presented different histopathological changes after NTC. There were significant relationship between curative effect and patients age (Z=-1.993, P=0.046 ), histological grade (χ2=7.261, P=0.027), molecular subtypes (χ2=8.289, P=0.040), while it had no statistical relationship between curative effect and tumor size (Z=-1.091, P=0.275) and lymph node status (Z=-1.107, P = 0.268). Expression of ER, PR, HER-2 and Ki-67 showed different degrees of change before and after NTC. The concordance rates of ER, PR, HER-2 and Ki-67 were 81.0％, 72.2％, 83.5％ and 55.7％, respective-ly. And there was no significant difference in expression of these four molecular indicators before and after NTC (χ2 =0.428, P=0.934). Conclusion The histomorphology of tumor cell, tumor stroma and lymph node status can be influenced by NTC. Objective evaluation of the changes of histopathology and molecular indicators after NTC may valuable in predicting clinical prognosis and guiding individual treatment of breast cancer.
ABSTRACT
The heme regulated eukaryotic initiation factor 2α (eIF 2α) kinase, also called the heme regulated inhibitor (HRI), is a key regulator of protein synthesis in mammalian reticulocyte. HRI is almost undetectable in blood samples of normal rabbits and it increases by 12 15 fold in the reticulocytes of anemic rabbits. In order to determine if such an increase in the quantity of HRI is gradual during anemia, and if it could be an indicator of anemia, we have carried out a detailed analysis on the expression of HRI and its eIF 2α kinase activity in rabbit reticulocyte lysates during various stages of acetylphenylhydrazine (APH) induced anemia. In a 9 day schedule of induction of anemia, using an anti HRI monoclonal antibody, HRI was detectable immediately after completion of fourth injection (day 5) and it increased gradually during the entire period reaching its maximum (24 fold) on day 9. Furthermore, when rabbits recovered from anemia due to individual response to the drug, quantity of HRI decreased significantly. Northern blot analysis results were similar to those of the Western blot. The other parameters that are generally used to monitor anemia in human patients, namely, reticulocyte count, haematocrit level and haemoglobin content although changed at the onset of anemia, did not change significantly during its progression. These results thus indicate that HRI could be a more appropriate and sensitive indicator of drug induced anemia.